Marius Pearson
HEOR and market access are evolving, with changes in HTA, acceleration in the use of RWE and increased reactions to cost-containment measures. We are contributing to conversations about how these changes affect value demonstration strategies. At Oxford PharmaGenesis, we are experts in advising on payer strategy, developing payer evidence and supporting payer evaluation. We understand differences in payer evidence needs, and we know how to create compelling value stories for our clients that achieve powerful results.
Oxford PharmaGenesis is global, award-winning and independent. Our unique HealthScience approach combines audience insights, best practice in omnichannel communications and proven behaviour change techniques to maximize your impact. From Medical Affairs to Market Access, join us to explore new frontiers.
Integrated evidence generation planning is more effective than traditional evidence generation planning. It can help pharmaceutical organizations to improve patient care and outcomes.
The 2024 European meeting of the International Society for Medical Publication Professionals (ISMPP), held on 23–24 January 2024, saw professionals from all areas of medical communications gather in the Novotel London West to shelter from some quintessentially British weather. I started working at Oxford PharmaGenesis only a couple of months before the world locked down […]
Following an invitation from MAPS (Medical Affairs Professional Society), Oxford PharmaGenesis Communications Director Gary Male has joined the Evidence Generation Focus Area Working Group (FAWG). He will volunteer his time and expertise to help to educate the society’s membership of Medical Affairs professionals about this specialty area.
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published today in the non-profit open access journal PLOS Medicine.
Oxford PharmaGenesis is global, award winning and independent. Our unique HealthScience approach uses proven behaviour change techniques to maximize the impact of your communications and to ensure they resonate with the target audience. Talk to us to learn how we can help you improve collaboration, innovation, and strategy and planning.
Oxford PharmaGenesis has enjoyed another great year of bringing success for clients. From innovative studies to employee milestones, to a prestigious King’s Award, here is a round-up of our top highlights and most viewed headlines of the year. Read on to find out what we have been up to in 2023, and if you are […]
Oxford PharmaGenesis joins with local businesses to make Oxfordshire a better place to live and work
Oxford PharmaGenesis has joined the Oxfordshire Collective Business Fund, a way for the UK county’s local companies to make a genuine difference to communities by investing in local charitable organizations. Hosted by the Oxfordshire Community Foundation (OCF), a charity that builds thriving communities through effective philanthropy, the fund brings together Oxfordshire companies keen to be […]
This year’s Medical Affairs Professionals of Australasia (MAPA) and Medical Affairs Professional Society (MAPS) Medical Affairs Summit was held from 8 to 10 November 2023 in Sydney, Australia.
